Workboat Indexes
Latest News about JNJ
Recent news which mentions JNJ
From InvestorPlace
Will The Bears Deliver The Knockout? Prepare For The Upcoming Week With Mando Trading!
August 21, 2023
From Benzinga
‘The sharks are still there.’ Stock market’s decline is just beginning, this top fund manager says
August 21, 2023
From MarketWatch
The 7 Most Undervalued Dividend Stocks to Buy Now: August 2023
August 20, 2023
From InvestorPlace
3 Stocks I Will "Never" Sell
August 20, 2023
From Motley Fool
Europe Approves Reduced Dosing For Johnson & Johnson's Cell Therapy For Multiple Myeloma
August 18, 2023
Tickers
JNJ
From Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
August 18, 2023
From Benzinga
From Motley Fool
The 3 Most Undervalued Retirement Stocks to Buy Now: August 2023
August 16, 2023
From InvestorPlace
From Benzinga
Nearing Retirement? These Stocks Are as Safe as They Come
August 16, 2023
From Motley Fool
A New Stock Is About to Join the S&P 500. Does History Show That Buying It Now Could Pay Off?
August 16, 2023
From Motley Fool
Investors Look at Apple, Amazon, and More
August 14, 2023
From Motley Fool
7 Dividend Stocks to Buy as Investor Sentiment Falters
August 14, 2023
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
August 14, 2023
From Benzinga
Meet the Only 2 Publicly Traded Companies With a Higher Credit Rating Than the U.S. Government
August 14, 2023
From Motley Fool
3 Unstoppable Dividend Stocks to Buy Right Now
August 12, 2023
From Motley Fool
Boston Scientific's Farapulse Eyes Stronger US Market Position With Potential FDA Approval
August 11, 2023
From Benzinga
Supreme Court Halts Purdue Pharma's $6B Settlement: Sackler Family's Shield From Opioid Lawsuits Challenged
August 10, 2023
From Benzinga
KVUE Stock Alert: Kenvue to Join the S&P 500
August 10, 2023
From InvestorPlace
The 7 Safest Stocks to Buy in August
August 10, 2023
From InvestorPlace
Kenvue, the J&J spinoff, will join the S&P 500 index
August 09, 2023
From MarketWatch
Atai's Clinical Results Of R-Ketamine For Depression: Road To Subcutaneous At-Home Administration
August 09, 2023
From Benzinga
Looking At Johnson & Johnson's Recent Unusual Options Activity
August 09, 2023
Tickers
JNJ
From Benzinga
The Year’s Top 3 Value ETFs as of August 2023
August 09, 2023
From InvestorPlace
Johnson & Johnson's Talc Problems Aren't Going Away
August 09, 2023
From Motley Fool
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.